Brief: Alzinova Signs LoI With Fujirebio
24/06/2026 08:07
BRIEF-Alzinova Signs LoI With Fujirebio June 24 (Reuters) - Alzinova AB ALZ.ST:
ALZINOVA SIGNS LETTER OF INTENT WITH FUJIREBIO REGARDING POTENTIAL COMMERCIALIZATION OF BLOOD-BASED ALZHEIMER'S DIAGNOSTIC TEST
POTENTIAL EXCLUSIVE LICENSE AND COMMERCIAL RIGHTS FOR FUJIREBIO SUBJECT TO VALIDATION DATA
Source text: ID:nMFN6nrzv2
Further company coverage: ALZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))